ReviR Therapeutics

Brisbane, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Apr 2026

Corporate Round

Alternative Medicine Artificial Intelligence (AI)Biotechnology Genetics Therapeutics

Top Investors

Sky9 CapitalCDH InvestmentsXtalPiShunwei Capital5Y Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ReviR Therapeutics

Who are ReviR Therapeutics's investors?

ReviR Therapeutics's investors include Sky9 Capital, CDH Investments, XtalPi, Shunwei Capital, 5Y Capital.

Where is ReviR Therapeutics headquartered?

ReviR Therapeutics is headquartered in Brisbane, United States.

What does ReviR Therapeutics do?

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

What stage is ReviR Therapeutics at?

ReviR Therapeutics is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 21, 2026.

MLA

"ReviR Therapeutics — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/revir-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). ReviR Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/revir-therapeutics

Wikipedia (cite web)

{{cite web |title=ReviR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/revir-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 21, 2026.

Similar Companies in Alternative Medicine